Comments
Loading...

Turnstone Biologics

TSBXNASDAQ
Logo brought to you by Benzinga Data
$0.4537
0.001620.36%
At close: -
$0.4658
0.012.66%
After Hours: 7:04 AM EDT
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$0.50
Consensus Price Target1
$4.75

Turnstone Biologics (NASDAQ:TSBX) Stock, Analyst Ratings, Price Targets, Forecasts

Turnstone Biologics Corp has a consensus price target of $4.75 based on the ratings of 3 analysts. The high is $10 issued by B of A Securities on August 19, 2024. The low is $0.5 issued by B of A Securities on October 14, 2024. The 3 most-recent analyst ratings were released by B of A Securities, B of A Securities, and Piper Sandler on October 14, 2024, August 19, 2024, and August 19, 2024, respectively. With an average price target of $4.75 between B of A Securities, B of A Securities, and Piper Sandler, there's an implied 919.75% upside for Turnstone Biologics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Aug
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
B of A Securities
Piper Sandler

1calculated from analyst ratings

Analyst Ratings for Turnstone Biologics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Turnstone Biologics (TSBX) stock?

A

The latest price target for Turnstone Biologics (NASDAQ:TSBX) was reported by B of A Securities on October 14, 2024. The analyst firm set a price target for $0.50 expecting TSBX to rise to within 12 months (a possible 7.34% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Turnstone Biologics (TSBX)?

A

The latest analyst rating for Turnstone Biologics (NASDAQ:TSBX) was provided by B of A Securities, and Turnstone Biologics downgraded their neutral rating.

Q

When was the last upgrade for Turnstone Biologics (TSBX)?

A

There is no last upgrade for Turnstone Biologics

Q

When was the last downgrade for Turnstone Biologics (TSBX)?

A

The last downgrade for Turnstone Biologics Corp happened on October 14, 2024 when B of A Securities changed their price target from $10 to $0.5 for Turnstone Biologics Corp.

Q

When is the next analyst rating going to be posted or updated for Turnstone Biologics (TSBX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Turnstone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Turnstone Biologics was filed on October 14, 2024 so you should expect the next rating to be made available sometime around October 14, 2025.

Q

Is the Analyst Rating Turnstone Biologics (TSBX) correct?

A

While ratings are subjective and will change, the latest Turnstone Biologics (TSBX) rating was a downgraded with a price target of $10.00 to $0.50. The current price Turnstone Biologics (TSBX) is trading at is $0.47, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch